| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/27/2003 | EP1337251A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors |
| 08/27/2003 | EP1337250A2 Use of p38 inhibitors for the treatment of smoke inhalation |
| 08/27/2003 | EP1337249A1 Compositions and methods for administration of pharmacologically active compounds |
| 08/27/2003 | EP1337248A1 Methods for treatment of inflammatory diseases |
| 08/27/2003 | EP1337247A1 Gaba enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 08/27/2003 | EP1337246A2 Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence |
| 08/27/2003 | EP1337244A1 Controlled release hydrocodone formulations |
| 08/27/2003 | EP1337241A2 Pharmaceutical compositions for inhalation |
| 08/27/2003 | EP1337240A2 Method of making particles for use in a pharmaceutical composition |
| 08/27/2003 | EP1337236A1 Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition |
| 08/27/2003 | EP1337235A1 Cosmetic method of treating skin |
| 08/27/2003 | EP1337234A1 Use of 2-oxothiazolidine 4-carboxylic acid derivatives as agents promoting skin peeling |
| 08/27/2003 | EP1337233A1 Use of at least a sulphonic amino derivative in a composition promoting skin peeling |
| 08/27/2003 | EP1337228A2 Compositions for removing human cerumen |
| 08/27/2003 | EP1337220A2 Compositions having comfrey and methods for reducing retinoid-induced skin irritation |
| 08/27/2003 | EP1337218A2 Substituted felbamate derived compounds |
| 08/27/2003 | EP1337149A2 Vaccine immunotherapy for immune suppressed patients |
| 08/27/2003 | EP1296703A4 Non-antibacterial tetracycline as anti-fungal agents |
| 08/27/2003 | EP1267834A4 Cationic liposomes |
| 08/27/2003 | EP1261593B1 8,8a-dihydro-indeno 1,2-d]thiazole derivatives with a sulphonamido or sulphono substituent in the 2 position, a method for production thereof and use thereof as a medicament |
| 08/27/2003 | EP1259244B1 Veterinary compositions for the treatment of parasitic diseases |
| 08/27/2003 | EP1251842B1 Use of modafinil for the manufacture of a medicament for correcting vigilance disorders related to myopathies |
| 08/27/2003 | EP1237569B1 An additive for an animal feed |
| 08/27/2003 | EP1193266B1 Quinolinecarboxylic acid derivative or salts thereof |
| 08/27/2003 | EP1189617B1 Pharmaceutical combination with analgesic action containing paracetamol and buspirone |
| 08/27/2003 | EP1185540B1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents |
| 08/27/2003 | EP1169046B1 Pulmonary delivery of protonated/acidified nucleic acids |
| 08/27/2003 | EP1161228B1 Composition comprising isoquercetin and ascorbic acid in a sustained release form |
| 08/27/2003 | EP1152748B1 Method and composition for treating acne |
| 08/27/2003 | EP1143920B1 Oil-in-water emulsion comprising a micronised biologically active agent and an appropriate emulsifier system |
| 08/27/2003 | EP1140944B1 Epothilone derivatives and their use as antitumor agents |
| 08/27/2003 | EP1140938B1 High affinity inhibitors for target validation and uses thereof |
| 08/27/2003 | EP1140889B1 Compounds and methods for modulation of estrogen receptors |
| 08/27/2003 | EP1124831B1 Sodium salt of 3-(4-cinnamyl-1-piperazinyl)imino-methyl rifamycin sv and process of preparation |
| 08/27/2003 | EP1115384B1 Fentanyl composition for the treatment of acute pain |
| 08/27/2003 | EP1109806B1 Complexes of paroxetine, with cyclodextrins or cyclodextrin derivates |
| 08/27/2003 | EP1100508B1 Pharmaceutical combination comprising a tricyclic compound and at least one of zolpidem, zopiclone and brotizolam for treating or preventing sleep disorders |
| 08/27/2003 | EP1095039B1 New pharmaceutically active compounds |
| 08/27/2003 | EP1073672B1 Antipicornaviral compounds, their preparation and use |
| 08/27/2003 | EP1070057B1 Use of 7-acyltaxols for the treatment of multidrug resistant cells |
| 08/27/2003 | EP1059845B1 Fungicide composition comprising a benzoylphenylurea |
| 08/27/2003 | EP1036794B1 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof |
| 08/27/2003 | EP1021178B1 Selenophene anti-tumor agents |
| 08/27/2003 | EP1014952B1 Multiple unit effervescent dosage form |
| 08/27/2003 | EP1011687A4 13-deoxyanthracycline derivatives and processes for preparing them |
| 08/27/2003 | EP1007520B1 2-aminopyridines containing fused ring substituents as nos inhibitors |
| 08/27/2003 | EP0988057B1 Bioreductive conjugates for drug targeting |
| 08/27/2003 | EP0981515B1 Piperidine derivatives as neurotransmitter re-uptake inhibitors |
| 08/27/2003 | EP0968211B1 Tetrazole derivatives |
| 08/27/2003 | EP0946567B1 Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them |
| 08/27/2003 | EP0942740B1 Combination therapy using a tnf binding protein for treating tnf-mediated diseases |
| 08/27/2003 | EP0942720B1 Use of metal complexes to treat gastrointestinal infections |
| 08/27/2003 | EP0920314B1 Non-peptide g-csf mimetics |
| 08/27/2003 | EP0914126B1 Sustained release sufentanil compositions |
| 08/27/2003 | EP0906089B1 Buccal delivery system |
| 08/27/2003 | EP0901469B1 Arylalkylpiperazine compounds as antioxidants |
| 08/27/2003 | EP0896525B1 Methods of dry powder inhalation |
| 08/27/2003 | EP0891363B1 Heterocyclic compounds and their preparation and use |
| 08/27/2003 | EP0885005B1 Combination of dehydroepiandrosterone and aromatase inhibitors and use of this combination to produce a medicament for treating relative and absolute androgen deficiency in men |
| 08/27/2003 | EP0874809B1 Carbamoyloxy derivatives of mutiline and their use as antibacterials |
| 08/27/2003 | EP0862552B1 Succinimide and maleimide cytokine inhibitors |
| 08/27/2003 | EP0815084B1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease |
| 08/27/2003 | EP0806206B1 Aqueous compositions containing ciprofloxacine, and related use and process |
| 08/27/2003 | EP0802182B1 PROCESS FOR PRODUCING N-(D-alpha-METHYL-beta-MERCAPTOPROPIONYL)-L-PROLINE AND INTERMEDIATES THEREOF |
| 08/27/2003 | EP0785927B1 Novel benzoxazoles |
| 08/27/2003 | EP0758237B1 Lactone stable formulation of camptothecin or 7-ethyl camptothecin in dimethylisosorbide or dimethylacetamide |
| 08/27/2003 | EP0739342B1 Pyridine modulators of acetylcholine receptors |
| 08/27/2003 | EP0735881B1 Means and method for hormonal contraception and/or the treatment of acne |
| 08/27/2003 | EP0727947B1 Beverage comprising alpha-ketoglutaric acid |
| 08/27/2003 | EP0644760B1 Use of imidazole for the treatment of diseases characterized by neovascularization |
| 08/27/2003 | CN1439022A Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 08/27/2003 | CN1439021A Parathyroid hormone and parathyroid hormone-related protein receptor modulators |
| 08/27/2003 | CN1439018A 9alpha-chloro-6alpha-fluoro-17alpha-hydroxy-16-methyl-17-beta-methoxy carbonyl-androst-1, 4-dienes esterified in position 17 alpha by a cyclic acyl group |
| 08/27/2003 | CN1439014A Novel cephalosporin compounds and process for preparing the same |
| 08/27/2003 | CN1439013A Process for preparing a pure, pharmacopoeial grade amorphous form of cefuroxime axetil |
| 08/27/2003 | CN1439012A 2-zminoalkyl-thieno [2,3-D] pyrimidines |
| 08/27/2003 | CN1439011A 5-aminoalkyl-pyrazolo [4,3-d] pyrimidines with phosphodiesterase v-inhibiting effect |
| 08/27/2003 | CN1439010A Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents |
| 08/27/2003 | CN1439009A Imidazo pyrimidine derivatives and triazolopyrimidine derivatives |
| 08/27/2003 | CN1439008A 1-(heteroaryl-henyl)-condensed pyrazol derivatives as factor XA inhibitors |
| 08/27/2003 | CN1439006A Novel compounds possessing antibacterial, antifungal or antitumor activity |
| 08/27/2003 | CN1439005A Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/27/2003 | CN1439004A Indole derivatives useful for treatment of CNS-disorders |
| 08/27/2003 | CN1439003A Arylmethy lamine derivatives for use as tryptase inhibitors |
| 08/27/2003 | CN1439002A Muscarinic agonists |
| 08/27/2003 | CN1439001A Tetrahydropyridino or piperidino hetlrocyclic derivatives |
| 08/27/2003 | CN1438999A Serine protease inhibitors |
| 08/27/2003 | CN1438998A Quinolinyl and benzothiazolyc PPAR-gamma modulators |
| 08/27/2003 | CN1438997A Inhibitors of 11-beta-hydroxy steroid dehydrogenase typeÔàá" |
| 08/27/2003 | CN1438996A Bicyclic cyclohexylamines and their use NMDA receptor antogonists |
| 08/27/2003 | CN1438994A Polymorphic forms/hydrates of N-[4-(3-chloro-4-fluoro-phenylamino)-7- (3-morpholin-4-ylpropoxy)-quinazolin-6-Yl] acrylamide dihydrochloride |
| 08/27/2003 | CN1438992A Biocidal polymers based on guanidine salts |
| 08/27/2003 | CN1438991A Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 08/27/2003 | CN1438989A Novel amorphous form of sertraline hydrochloride |
| 08/27/2003 | CN1438900A A Novel treatment for cough |
| 08/27/2003 | CN1438897A Remedial agent for anxiety neurosis or depression and piperazine derivative |
| 08/27/2003 | CN1438892A Low carbony drate compositions, kits thereof, and methods of use |
| 08/27/2003 | CN1438891A Nucleoside analogs with carboxamidine wodified monocyclic base |
| 08/27/2003 | CN1438890A 腺苷受体调制剂 Adenosine receptor modulators |
| 08/27/2003 | CN1438889A Sustained-release preparations of quinolone antibiotics and method for prepartion thereof |